JP Morgan raises Ashland price target to $75

0 min read | Published on 11 Jul 2026, 12:12 AM |Updated on 11 Jul 2026, 12:12 AM

Reviewed by

Radhika SScanX News Team

Key Highlights

JP Morgan maintained an Overweight rating on Ashland and raised the price target to $75 from $65, signaling a positive outlook.

*this image is generated using AI for illustrative purposes only.

JP Morgan analyst Jeffrey Zekauskas has maintained an Overweight rating on Ashland while raising the stock's price target. The new target stands at $75, an increase from the previous $65. This adjustment reflects a revised outlook on the company's valuation.

The rating indicates that JP Morgan expects Ashland's shares to outperform the broader market. The price target increase suggests confidence in the company's financial performance and strategic direction.

What specific factors drove JP Morgan to revise Ashland's valuation upwards?

How might Ashland's strategic initiatives contribute to its outperformance of the broader market?

What are the potential risks that could hinder Ashland from reaching the new $75 price target?

Activist Cruiser pushes Ashland to explore sale

0 min read | Published on 18 Jun 2026, 06:39 PM |Updated on 18 Jun 2026, 06:39 PM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

Key Highlights

Activist investor Cruiser has urged chemicals maker Ashland to explore a potential sale, aiming to unlock shareholder value through strategic alternatives.

*this image is generated using AI for illustrative purposes only.

Activist investor Cruiser has urged chemicals maker Ashland to explore a potential sale, according to a report. The campaign aims to unlock shareholder value by encouraging the company to consider strategic alternatives, including a possible transaction.

Cruiser's push comes as it seeks to drive changes at Ashland. The activist believes that a sale could provide a premium to current shareholders. Ashland has not yet publicly responded to the specific demands outlined by Cruiser.

The development highlights increasing activist interest in the chemicals sector. Ashland's board will likely need to evaluate the proposal and determine the best path forward for the company and its investors.

How might Ashland's board respond to Cruiser's demands, and what strategic alternatives could they consider?

Who are the potential buyers for Ashland, and could a sale attract interest from private equity or strategic competitors?

What impact could this activist campaign have on Ashland's stock price and shareholder sentiment in the short term?